Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Technique and Intraprocedural Imaging

Saher S Sabri; Wael E. A. Saad

doi:10.1055/s-0031-1284457

Seminars in Interventional Radiology, Table of Contents

Semin intervent Radiol 2011; 28(3): 303-313
DOI: 10.1055/s-0031-1284457

Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Technique and Intraprocedural Imaging

Saher S. Sabri¹ , Wael E. A. Saad¹

¹Division of Interventional Radiology, Department of Radiology and Medical Imaging, University of Virginia Health System, Charlottesville, Virginia

Abstract

ABSTRACT

Balloon-occluded retrograde transvenous obliteration (BRTO) is an endovascular technique used as a therapeutic adjunct or alternative to transjugular intrahepatic shunts (TIPS) in the management of gastric varices. Occlusion balloons are strategically placed to modulate flow within the gastrorenal or gastrocaval shunt to allow stagnation of the sclerosant material within the gastric varix. The approach and complexity of the procedure depends on the anatomic classification of inflow and outflow veins of the varix. Ethanolamine oleate has been described as the main sclerosant used in this procedure. Recently, foam sclerosants have gained popularity as alternative embolization agents, which provide the advantage of better variceal wall contact and potentially less dose of sclerosant.

KEYWORDS

Gastric varices - portal hypertension - liver cirrhosis - BRTO - portosystemic shunt - embolization

Full Text

References

REFERENCES

1 Sarin S K, Lahoti D, Saxena S P, Murthy N S, Makwana U K. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology. 1992; 16 (6) 1343-1349
2 Kim T, Shijo H, Kokawa H et al.. Risk factors for hemorrhage from gastric fundal varices. Hepatology. 1997; 25 (2) 307-312
3 Ryan B M, Stockbrugger R W, Ryan J M. A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices. Gastroenterology. 2004; 126 (4) 1175-1189
4 Rössle M, Haag K, Ochs A et al.. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med. 1994; 330 (3) 165-171
5 Rössle M, Siegerstetter V, Olschewski M, Ochs A, Berger E, Haag K. How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts. Am J Gastroenterol. 2001; 96 (12) 3379-3383
6 Tripathi D, Therapondos G, Jackson E, Redhead D N, Hayes P C. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut. 2002; 51 (2) 270-274
7 Zhuang Z W, Teng G J, Jeffery R F, Gemery J M, Janne d'Othee B, Bettmann M A. Long-term results and quality of life in patients treated with transjugular intrahepatic portosystemic shunts. AJR Am J Roentgenol. 2002; 179 (6) 1597-1603
8 Boyer T D, Haskal Z J. American Association for the Study of Liver Diseases . The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology. 2005; 41 (2) 386-400
9 Jalan R, Hayes P C. British Society of Gastroenterology . UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut. 2000; 46 (Suppl 3-4) III1-III15
10 Abi-Jaoudeh N, Matsumoto A H, Angle J F et al.. TIPS rebleeding rates for different subtypes of varices in the era of covered stents. J Vasc Interv Radiol. 2008; 19 (Suppl 1) S77-S78 (Abstract)
11 Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol. 1996; 11 (1) 51-58
12 Chikamori F, Shibuya S, Takase Y, Ozaki A, Fukao K. Transjugular retrograde obliteration for gastric varices. Abdom Imaging. 1996; 21 (4) 299-303
13 Hiraga N, Aikata H, Takaki S et al.. The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration. J Gastroenterol. 2007; 42 (8) 663-672
14 Chikamori F, Kuniyoshi N, Shibuya S, Takase Y. Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunts. Surgery. 2001; 129 (4) 414-420
15 Kiyosue H, Mori H, Matsumoto S, Yamada Y, Hori Y, Okino Y. Transcatheter obliteration of gastric varices. Part 1. Anatomic classification. Radiographics. 2003; 23 (4) 911-920
16 Kiyosue H, Mori H, Matsumoto S, Yamada Y, Hori Y, Okino Y. Transcatheter obliteration of gastric varices: Part 2. Strategy and techniques based on hemodynamic features. Radiographics. 2003; 23 (4) 921-937 discussion 937
17 Fukuda T, Hirota S, Sugimoto K, Matsumoto S, Zamora C A, Sugimura K. “Downgrading” of gastric varices with multiple collateral veins in balloon-occluded retrograde transvenous obliteration. J Vasc Interv Radiol. 2005; 16 (10) 1379-1383
18 Demagny A. Comparative study into the efficacy of a sclerosant product in the form of liquid or foam in echo-guided of arches of the long and short saphenous veins. Phlebologie. 2002; 55 133-137
19 Coleridge Smith P. Sclerotherapy and foam sclerotherapy for varicose veins. Phlebology. 2009; 24 (6) 260-269
20 Gandini R, Chiocchi M, Konda D, Pampana E, Fabiano S, Simonetti G. Transcatheter foam sclerotherapy of symptomatic female varicocele with sodium-tetradecyl-sulfate foam. Cardiovasc Intervent Radiol. 2008; 31 (4) 778-784
21 Gandini R, Konda D, Reale C A et al.. Male varicocele: transcatheter foam sclerotherapy with sodium tetradecyl sulfate—outcome in 244 patients. Radiology. 2008; 246 (2) 612-618
22 Tan K T, Kirby J, Rajan D K, Hayeems E, Beecroft J R, Simons M E. Percutaneous sodium tetradecyl sulfate sclerotherapy for peripheral venous vascular malformations: a single-center experience. J Vasc Interv Radiol. 2007; 18 (3) 343-351
23 Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg. 2008; 47 (3) 578-584
24 Sabri S S, Swee W, Turba U C et al.. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam. J Vasc Interv Radiol. 2011; 22 (3) 309-316 quiz 316
25 Koizumi J, Hashimoto T, Myojin K et al.. C-arm CT-guided foam sclerotherapy for the treatment of gastric varices. J Vasc Interv Radiol. 2010; 21 (10) 1583-1587
26 Orsini C, Brotto M. Immediate pathologic effects on the vein wall of foam sclerotherapy. Dermatol Surg. 2007; 33 (10) 1250-1254
27 Ceulen R P, Sommer A, Vernooy K. Microembolism during foam sclerotherapy of varicose veins. N Engl J Med. 2008; 358 (14) 1525-1526
28 Forlee M V, Grouden M, Moore D J, Shanik G. Stroke after varicose vein foam injection sclerotherapy. J Vasc Surg. 2006; 43 (1) 162-164
29 Park S J, Chung J W, Kim H C, Jae H J, Park J H. The prevalence, risk factors, and clinical outcome of balloon rupture in balloon-occluded retrograde transvenous obliteration of gastric varices. J Vasc Interv Radiol. 2010; 21 (4) 503-507

Saher S SabriM.D.

Department of Radiology and Medical Imaging, University of Virginia Health System

Box 800170, 1215 Lee Street, Charlottesville, VA 22908

Email: ss2bp@virginia.edu